Author

Sabela Lens

Presentation by UEG Rising Star 2021
Presentation by UEG Rising Star 2021

Sabela Lens

SIGNIFICANT HARM REDUCTION DESPITE HIGH REINFECTION RATES AMONG ACTIVE PEOPLE WHO INJECT DRUGS ENROLLING IN AN EXTERNALIZED MODEL FOR HCV MICROELIMINATION
SIGNIFICANT HARM REDUCTION DESPITE HIGH REINFECTION RATES AMONG ACTIVE PEOPLE WHO INJECT DRUGS ENROLLING IN AN EXTERNALIZED MODEL FOR HCV MICROELIMINATION

SIGNIFICANT HARM REDUCTION DESPITE HIGH REINFECTION RATES AMONG ACTIVE PEOPLE WHO INJECT DRUGS ENROLLING IN AN EXTERNALIZED MODEL FOR HCV MICROELIMINATION
SIGNIFICANT HARM REDUCTION DESPITE HIGH REINFECTION RATES AMONG ACTIVE PEOPLE WHO INJECT DRUGS ENROLLING IN AN EXTERNALIZED MODEL FOR HCV MICROELIMINATION

Sabela Lens  et al.

Management and treatment of HBV/HDV coinfection in cirrhosis:...
Management and treatment of HBV/HDV coinfection in cirrhosis:...

Sabela Lens

Early HBV infection in infancy induces changes in the memory B cell compartment and HBV-specific B cell responses
Early HBV infection in infancy induces changes in the memory B cell compartment and HBV-specific B cell responses

Sabela Lens

What is left in HCV in terms of clinical challenges
What is left in HCV in terms of clinical challenges

Sabela Lens

NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION
NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION

Sabela Lens  et al.

PROGNOSTIC UTILITY OF THE BAVENO VII CRITERIA FOR A CLINICALLY SIGNIFICANT DECREASE IN LIVER STIFFNESS MEASUREMENT AFTER HCV-CURE
PROGNOSTIC UTILITY OF THE BAVENO VII CRITERIA FOR A CLINICALLY SIGNIFICANT DECREASE IN LIVER STIFFNESS MEASUREMENT AFTER HCV-CURE

Sabela Lens  et al.

THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE
THE RISKS OF FIRST HEPATIC DECOMPENSATION AND HCC REMAIN CONSTANT DURING LONG-TERM FOLLOW-UP AND CAN BE STRATIFIED BY A ONE-TIME ASSESSMENT AFTER HCV-CURE

Sabela Lens  et al.

VALIDATION AND REFINEMENT OF THE BAVENO VII CRITERIA FOR RISK STRATIFICATION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE AFTER HCV-CURE
VALIDATION AND REFINEMENT OF THE BAVENO VII CRITERIA FOR RISK STRATIFICATION IN COMPENSATED ADVANCED CHRONIC LIVER DISEASE AFTER HCV-CURE

Sabela Lens  et al.

LIFESTYLE CHANGES OF CURED HEPATITIS C PATIENTS IN A NURSE-LED LIVER CANCER SCREENING PROGRAM
LIFESTYLE CHANGES OF CURED HEPATITIS C PATIENTS IN A NURSE-LED LIVER CANCER SCREENING PROGRAM

Sabela Lens  et al.

LOW LEVELS OF QHBSAG AND LONG TERM ANTIVIRAL THERAPY ARE ASSOCIATED WITH SUCCESSFUL TREATMENT WITHDRAWAL IN NON-CIRRHOTIC HBEAG-NEGATIVE CHRONIC HEPATITIS B
LOW LEVELS OF QHBSAG AND LONG TERM ANTIVIRAL THERAPY ARE ASSOCIATED WITH SUCCESSFUL TREATMENT WITHDRAWAL IN NON-CIRRHOTIC HBEAG-NEGATIVE CHRONIC HEPATITIS B

Sabela Lens  et al.

Item 1 - 12 / 12
1